IMT504 is a novel immunotherapy molecule that has demonstrated the ability to regenerate insulin-producing beta cells in multiple mouse diabetes models, enabling complete blood glucose control without additional interven...
Next-generation drug discovery platform combining proprietary ultra-high-throughput X-ray crystallography screening with AI/ML analytics to identify novel, patentable inhibitors of Fusarium trichodiene synthase (TRI5), a...